●政策、计划和立法办公室 Office of Policy, Planning, and Legislation (职位:资深准专员Senior Associate Commissioner) ▲政策办公室 Office of Policy ▲计划办公室 Office of Planning ▲立法办公室 Office of Legislation ●管理和系统办公室 Office of Management & Systems (职位:资深准专员Senior Associate Com...
◆选民工作办公室 Office of Constituent Operations ▲管理系统办公室 Office of Management Systems ●运行办公室 Office of Operations ▲化妆品和色素办公室 Office of Cosmetics and Colors ▲上市前审批办公室 Office of Premarket Approval ▲植物和牛奶食品及饮料办公室 Office of Plant and Dairy Foods and Beve...
Office of Food Policy & Response 食品政策与反应办公室 Offic of Minority Health & Health Equity 少数民族健康与健康公平办公室 Office of Operations 行动办公室 Office of Policy,Legislation & International Affairs 政策,立法和国际事务办公室 Office of the Chief Scientist 首席科学家办公室 Offic of Women's...
分别是食品和兽药办公室(Office of Foods and Veterinary Medicine)、全球监管和政策办公室(Office of Global Regulatory Operations and Policy)、医疗产品和烟草办公室(Office of Medical Products and Tobacco)、运营办公室(Office of Operations)、政策规划法规和分析办公室(Office of Policy, Planning, Legislation an...
Sen. Grassley Plans Legislation On Independence Of FDA Drug Safety OfficeElizabeth Walker
Development 行业指南：有关仿制药研发的书面咨询 This guidance represents the current thinking of the Food and Drug Administration (FDA, or the Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach...
FDA’s Office of Generic Drugs provides assistance to pharmaceutical firms and related industry regarding a variety of questions po sed as “controlled documents.” See [ /ForIndustry/UserFees/GenericDrugUserFees/]. Controlled correspondence does not include citizen petitions, petitions for reconsideratio...
Guidance for Industry Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology Contains Nonbinding Recommendations June, 2014 Additional copies are available from: Office of Policy Office of the Commissioner Food and Drug Administration 10903 New Hampshire Avenue Silver Spring,...
FDA仿制药一致性评价指导指南(中英文版) Guidance for Industry Controlled Correspondence Related to Generic Drug Development 行业指南:有关仿制药研发的书面询问 This guidance represents the current thinking of the Food and Drug Administration (FDA, or the Agency) on this topic. It does not establish ...
FDA says the CDER Office of Prescription Drug Promotion will research how consumers and primary care...Medical Devices View All Multiple Violations in BD Inspection FDA warns Becton Dickinson about multiple violations at its San Diego facility that manufactures the... Updated POLARx Instructions is...